MBX Biosciences Inc. (MBX) Live Share Price, Invest From India

MBX Biosciences Inc. Stock Performance

as on July 3, 2026 at 2:15 pm IST

Day's Low
Day's High
$55.16
Day's Price Range
$58.32
$57.80
4.57%
Downside
0.90%
Upside
52 Week's Low
52 Week's High
$9.63
52-Week Price Range
$58.50
$57.80
83.34%
Downside
1.21%
Upside

MBX Biosciences Inc. share price movements today

Previous Close: $55.92
Open: $56.34
Volume: 830.5K
Day's Low - High: $55.16 - $58.32
52 Week Low - High: $9.63 - $58.50

MBX Biosciences Inc. Historical Returns

1 Month Return: + 92.35 %
3 Month Return: + 75.2 %
1 Year Return: + 363.51 %
3 Year Return: 0 %
5 Year Return: 0 %

MBX Biosciences Inc. Stock Fundamentals & Key Indicators

Check MBX Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

-2.7479

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-25.73%

MBX Biosciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MBX Biosciences Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
MBX Biosciences Inc.	NA	$2.7B	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.9B	478.19%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$40.3B	82.45%	75.8	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$126.4B	163.31%	29.59	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.5B	12.1%	15.25	29.65%	0.5700000000000001%

Stock Returns calculator for MBX Biosciences Inc. Stock including INR - Dollar returns

The MBX Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

MBX Biosciences Inc. investment value today

Current value as on today

₹5,16,506

Returns

₹4,16,506

(+416.51%)

Returns from MBX Biosciences Inc. Stock

₹3,63,512 (+363.51%)

Dollar Impact

₹52,993 (+52.99%)

Indian Investors' Interest in MBX Biosciences Inc. Stock

Search interest for MBX Biosciences Inc. Stock has increased by 125% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 4, 2026 to July 4, 2026

Change:125% versus previous 30 day period

MBX Biosciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	0	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	0	0	0
Operating Income	-9	-13	-16	-19	-18	-26	-21	-23	-25	-27
EBITDA	-7	-12	-15	-18	-15	-23	-19	-21	-22	-23
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-12	-15	-18	-15	-23	-19	-21	-22	-23
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-8	-12	-15	-18	-15	-23	-19	-21	-22	-23
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-7020.72%	0.00%	0.00%	0.00%	0.00%	0.00%

MBX Biosciences Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	0	0	0	0
Operating Income	-25	-35	-68	-98
EBITDA	-25	-32	-61	-86
Interest Expense	0	-	-	-
Depreciation	0	0	0	0
Income Before Tax	-26	-32	-61	-86
Income Tax Expense	-	-	-	-
Net Income	-26	-32	-61	-86
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

MBX Biosciences Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-12	-15	-18	-15	-23	-19	-21	-22	-23
Operating Cash Flow	-10	-13	-14	-16	-22	-17	-21	-18	-20
Investing Cash Flow	15	-7	-100	-67	3	25	17	-129	-97
Financing Cash Flow	0	-1	235	0	0	1	187	0	87
Change in Cash	35	-22	120	-83	-19	9	183	-147	-29

MBX Biosciences Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-32	-61	-86
Operating Cash Flow	-31	-54	-79
Investing Cash Flow	-30	-160	-83
Financing Cash Flow	69	234	189
Change in Cash	6	18	25

Global Institutional Holdings in MBX Biosciences Inc.

Funds	Holdings
Citadel Advisors Llc	1.96%
T. Rowe Price Associates, Inc.	2.16%
StemPoint Capital LP	2.1%
FMR Inc	6.17%
NVP Associates LLC	4.49%

See all

Insights on MBX Biosciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, MBX stock has moved up by 92.3%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.7% return, outperforming this stock by 36.2%

About MBX Biosciences Inc.

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is Canvuparatide (MBX 2109), a parathyroid hormone peptide prodrug, which is in Phase 3 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing Imapextide (MBX 1416), a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 2 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Organisation	MBX Biosciences Inc.
Headquarters	11711 North Meridian Street, Carmel, IN, United States, 46032
Industry	Biotechnology
CEO	Mr. Peter Kent Hawryluk MBA
E-voting on shares	Click here to vote

Key Management of MBX Biosciences Inc.

Name	Title
Mr. Peter Kent Hawryluk MBA	CEO, President & Director
Dr. Salomon Azoulay M.D.	Chief Medical Officer
Mr. Pete De Spain	Senior Vice President of Investor Relations & Corporate Communications
Dr. Michael A. Dorato DABT, Ph.D.	Sr. Vice President of Discovery & Non-Clinical Development
Dr. Andreas Moraitis M.D.	Senior Vice President of Clinical Development
Mr. Steven L. Hoerter	Executive Chairperson
Mr. John W. Smither CPA	Interim Chief Financial Officer
Ms. Michelle Graham	Chief Human Resources Officer
Dr. Chatan Charan Ph.D.	Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls
Mr. Mark Hope	Senior Vice President of Regulatory & Quality

FAQs

What is MBX Biosciences Inc. share price today?

MBX Biosciences Inc. share price today is $57.80 as on July 3, 2026 at 8:45 am IST at the close of the market. MBX Biosciences Inc. share today touched a day high of $58.32 and a low of $55.16.

What is the 52 week high and 52 week low for MBX Biosciences Inc. share?

MBX Biosciences Inc. share touched a 52 week high of $58.50 on July 1, 2026 and a 52 week low of $9.63 on September 12, 2025. MBX Biosciences Inc. stock price today i.e. July 3, 2026 at 8:45 am IST is closed at $57.80,which is 1.20% down from its 52 week high and 500.21% up from its 52 week low.

What is MBX Biosciences Inc.'s market capitalisation today?

MBX Biosciences Inc. market capitalisation is $0.00T as on July 3, 2026 at 8:45 am IST.

How to invest in MBX Biosciences Inc. Stock (MBX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for MBX Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MBX Biosciences Inc. Shares that will get you 0.0260 shares as per MBX Biosciences Inc. share price of $57.80 per share as on July 3, 2026 at 8:45 am IST.

What is the minimum amount required to buy MBX Biosciences Inc. Stock (MBX) from India?

Indian investors can start investing in MBX Biosciences Inc. (MBX) shares with as little as ₹95.2 or $1 (as of July 4, 2026 at 5:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in MBX Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on July 4, 2026 at 5:37 am IST). Based on MBX Biosciences Inc. share’s latest price of $57.80 as on July 3, 2026 at 8:45 am IST, you will get 0.1730 shares of MBX Biosciences Inc.. Learn more about fractional shares .